Skip to content
FDAMedical devicesClass IIOngoing

FDA recall 96688: Medtronic Neuromodulation: Enhanced Verify Evaluation Handset

FDA recall 96688 ·

Build snapshot. Collected , once, when this site was built. It is not a live feed.

Check my lot or code

Is yours in this recall?

Type the lot, batch, date code, model number or UPC printed on the product. It is compared here, in your browser, with the codes this notice lists. It stays in this page: it is not added to the address.

General information on recalls from the agency: U.S. Food and Drug Administration (opens in a new tab).

What the agency says to do

FDA’s record gives no instruction for consumers.

Status: Ongoing. What the FDA’s recall statuses mean (opens in a new tab)

Note from Recalls Watch, not agency text

Why it was recalled

Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior handsets. An inability to connect may cause the therapy to stop being delivered and a system error will be displayed. Patient may experience return of underlying disease symptoms (e.g. overactive bladder, urinary retention, or fecal incontinence) based on their response to stimulation during the evaluation period.
Text from FDA, unedited.

FDA classification: Class II. What the FDA’s classes mean (opens in a new tab)

The recalled product

Codes in the record. Click one to copy it.

392 more codes are in the record below.

  • Enhanced Verify Evaluation Handset (CFN HH90130FA)

    Lot or code
    UDI-DI 00763000930042 Serial Nos/Lots: NPN0076461 NPN0076462 NPN0076465 NPN0076466 NPN0076467 NPN0076468 NPN0076469 NPN0076470 NPN0076471 NPN0076472 NPN0076473 NPN0076474 NPN0076475 NPN0076476 NPN0076477 NPN0076479 NPN0076480 NPN0076482 NPN0076483 NPN0076485 NPN0076486 NPN0076487 NPN0076488 NPN0076489 NPN0076490 NPN0076491 NPN0076492 NPN0076493 NPN0076494 NPN0076495 NPN0076496 NPN0076497 NPN0076498 NPN0076499 NPN0076500 NPN0076501 NPN0076502 NPN0076504 NPN0076505 NPN0076506 NPN0076507 NPN0076508 NPN0076509 NPN0076510 NPN0076511 NPN0076512 NPN0076513 NPN0076514 NPN0076515 NPN0076516 NPN0076517 NPN0076518 NPN0076520 NPN0076522 NPN0076523 NPN0076524 NPN0076525 NPN0076526 NPN0076527 NPN0076528 NPN0076529 NPN0076530 NPN0076531 NPN0076532 NPN0076533 NPN0076534 NPN0076535 NPN0076536 NPN0076537 NPN0076538 NPN0076539 NPN0076540 NPN0076541 NPN0076542 NPN0076543 NPN0076545 NPN0076546 NPN0076548 NPN0076550 NPN0076551 NPN0076552 NPN0076553 NPN0076554 NPN0076555 NPN0076556 NPN0076557 NPN0076558 NPN0076559 NPN0076560 NPN0076561 NPN0076562 NPN0076563 NPN0076564 NPN0076565 NPN0076566 NPN0076567 NPN0076568 NPN0076569 NPN0076570 NPN0076571 NPN0076572 NPN0076573 NPN0076575 NPN0076577 NPN0076578 NPN0076579 NPN0076580 NPN0076581 NPN0076582 NPN0076583 NPN0076584 NPN0076585 NPN0076586 NPN0076587 NPN0076588 NPN0076589 NPN0076590 NPN0076591 NPN0076593 NPN0076594 NPN0076596 NPN0076598 NPN0076599 NPN0076602 NPN0076603 NPN0076605 NPN0076607 NPN0076608 NPN0076609 NPN0076610 NPN0076611 NPN0076612…
    FDA recall number
    Z-1704-2025
    Quantity
    534

    The text above is the beginning of the record; 4,422 more characters are in the official notice. See the full list in the official notice (opens in a new tab)

Distribution (FDA): US Nationwide distribution including in the states of AR, AZ, CA, CO, CT, FL, GA, IA, IL, IN, LA, MA, MD, MI, MN, MS, NC, NE, NJ, NM, NY, OH, OR, PA, TX, WA, WI.

Source

Issued by
U.S. Food and Drug Administration
Firm
Medtronic Neuromodulation
Title
Composed by Recalls Watch from fields of the record; FDA records have no title.

Check all notices that name this firm in the directory of recalls by brand and manufacturer. This notice is in these lists: Firm: Medtronic Neuromodulation, Month: May 2025, Week 2025-W19. Browse more medical devices recalls, or check another notice by its number in the recall number lookup.

About this recall

What is the hazard?

FDA states: “Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior handsets. An inability to connect may cause the therapy to stop being delivered and a system error will be displayed. Patient may experience return of underlying disease symptoms (e.g. overactive bladder, urinary retention, or fecal incontinence) based on their response to stimulation during the evaluation period.”

What should I do if I have this product?

FDA’s record gives no instruction for consumers. The official report is linked on this page.

How do I know if my product is included?

Compare the lot or code printed on your product with the codes FDA lists on this notice, product by product.

How does the code check on this page work?

You type the lot, batch, date code, model number or UPC from your package and the page compares it, in your browser, with the codes FDA lists on this notice. It reports a match, a possible match (your code is part of a longer listed code) or no match. It only compares text: a notice that describes products by dates, sizes or “all lots” cannot be compared, so “no match” does not clear a product. The comparison runs in your browser and the page does not send the code anywhere, and the code stays out of the page address. Only if you press “Copy link to this result” is a link made that carries it, and whoever opens that link requests that address from this site.

When was this recall published?

FDA published recall 96688 on May 7, 2025.

Other notices of Medtronic Neuromodulation